Clovis Oncology (CLVS) Short Interest Ratio & Short Volume

Short interest is the volume of Clovis Oncology shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 28,490,000 shares of CLVS short. Learn More on Clovis Oncology's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLVS shares currently have a short interest ratio of 7.0. Learn More on Clovis Oncology's short interest ratio.

Clovis Oncology saw a increase in short interest in November. As of November 30th, there was short interest totaling 28,490,000 shares, an increase of 1.7% from the previous total of 28,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "biotechnology" compare to Clovis Oncology: SAB Biotherapeutics, Inc. (0.95%), Curis, Inc. (2.31%), Bolt Biotherapeutics, Inc. (1.24%), Molecular Templates, Inc. (5.48%), Amgen Inc. (2.71%), Gilead Sciences, Inc. (1.62%), Vertex Pharmaceuticals Incorporated (1.70%), Regeneron Pharmaceuticals, Inc. (2.57%), Alnylam Pharmaceuticals, Inc. (2.40%), Biogen Inc. (2.37%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.93 billion), Suncor Energy Inc. ($3.50 billion), T. Rowe Price Group, Inc. ($2.29 billion), PG&E Co. ($1.73 billion), Coinbase Global, Inc. ($1.71 billion), Etsy, Inc. ($1.65 billion), Paramount Global ($1.54 billion), Lucid Group, Inc. ($1.50 billion), Old Dominion Freight Line, Inc. ($1.46 billion), and DICK'S Sporting Goods, Inc. ($1.41 billion). View all of the most shorted stocks.

Short selling CLVS is an investing strategy that aims to generate trading profit from Clovis Oncology as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Clovis Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLVS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLVS, twice per month. The most recent reporting period available is November, 30 2022.